Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-05
2006-09-05
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S253100, C514S253110, C514S253120, C514S254010, C544S360000, C544S364000, C544S372000
Reexamination Certificate
active
07101885
ABSTRACT:
The present invention relates to compounds of formula Iwherein Ar, Y and G are as defined in the specification, a is 1 to 4, Z and W are carbon or nitrogen and n is 1, 2 or 3; and to pharmaceutical compositions comprising the compound of formula I and a pharmaceutically effective carrier; and to a method useful in treating or preventing in mammals, including humans, a disorder or condition selected from the group consisting of anxiety, depression, dysthymia, major depressive disorder, migraine, post-traumatic stress disorder, avoidant personality disorder, borderline personality disorder and phobias.
REFERENCES:
patent: 9929666 (1999-06-01), None
patent: 0123374 (2001-04-01), None
Lowe, III John
Sanner Mark A.
Bernhardt Emily
Hosley Mary J.
Pfizer Inc
Zelson Steve T.
LandOfFree
Piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3565473